US Patent Issued to AEOVIAN PHARMACEUTICALS on March 3 for "mTORC modulators and uses thereof" (French, American Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,505, issued on March 3, was assigned to AEOVIAN PHARMACEUTICALS INC. (Berkeley, Calif.).

"mTORC modulators and uses thereof" was invented by Stelios T. Tzannis (Corte Madera, Calif.), Ian J. Massey (Los Altos, Calif.), Alexandre Froidbise (Gardouch, France) and Guillaume Eppe (Toulouse, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin."

The patent was filed on Dec. 16, 2021, under Application No. 17/553,409.

*For further information, including imag...